Stevanato Group S.p.A (STVN) Cash from Investing Activities (2020 - 2026)

Stevanato Group S.p.A (STVN) reported Cash from Investing Activities of -$82.4 million for Q1 2026, down 10.81% year-over-year from -$92.4 million in Q1 2025, and up 25.0% quarter-over-quarter from -$109.9 million in Q4 2025.

Stevanato Group S.p.A (STVN) Cash from Investing Activities (2020 - 2026) Analysis & Trends

Stevanato Group S.p.A (STVN) has 7 years of Cash from Investing Activities data on file, last reported at -$82.4 million in Q1 2026.

  • Cash from Investing Activities for Q1 2026 came in at -$82.4 million, down 10.81% year-over-year; the trailing twelve-month figure through Mar 2026 was -$316.2 million (down 5.85% YoY), and the FY2025 annual result was -$317.7 million, up 4.17% from the prior year.
  • Cash from Investing Activities improved to -$82.4 million in Q1 2026 per STVN's latest filing, from -$109.9 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at -$43.6 million in Q3 2022 and troughed at -$143.9 million in Q3 2023.
  • A 5-year average of -$85.5 million and a median of -$81.3 million in 2022 frame the typical range for Cash from Investing Activities.
  • The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities sank 230.4% in 2023, then soared 63.7% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at -$70.3 million in 2022, then sank by 41.27% to -$99.3 million in 2023, then climbed by 2.08% to -$97.2 million in 2024, then retreated by 13.0% to -$109.9 million in 2025, then rose by 25.0% to -$82.4 million in 2026.
  • Business Quant data shows STVN's Cash from Investing Activities at -$82.4 million in Q1 2026, -$109.9 million in Q4 2025, and -$56.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn -914.50 Mn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn -139.00 Mn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn -96.00 Mn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn -58.03 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn -42.70 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn -77.00 Mn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn -90.00 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn -131.58 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn -133.00 Mn
10 Stevanato Group S.p.A 433.37 Mn 290.42 Mn 88.01 Mn -82.42 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -82.42 Mn
Mar 31, 2026 -82.42 Mn
Dec 31, 2025 -109.89 Mn
Dec 31, 2025 -109.89 Mn
Sep 30, 2025 -56.34 Mn
Sep 30, 2025 -56.34 Mn
Jun 30, 2025 -67.53 Mn
Jun 30, 2025 -67.53 Mn
Mar 31, 2025 -74.38 Mn
Mar 31, 2025 -74.38 Mn
Dec 31, 2024 -97.24 Mn
Dec 31, 2024 -97.24 Mn
Sep 30, 2024 -52.24 Mn
Sep 30, 2024 -52.24 Mn
Jun 30, 2024 -74.84 Mn
Jun 30, 2024 -74.84 Mn
Mar 31, 2024 -110.93 Mn
Mar 31, 2024 -110.93 Mn
Dec 31, 2023 -99.31 Mn
Dec 31, 2023 -99.31 Mn